Press release
What Is Driving the Increased Incidence of Celiac Disease in Many Developed Countries?
According to a hypothesis developed by Seth Bittker of the Ronin Institute, one significant factor contributing to this rise in incidence may be the increase in vitamin D supplementation and fortification in many developed countries.Celiac researchers have known for a while that there has been a significant increase in the incidence of celiac disease in recent decades in many developed countries. Since some studies that show this are based on testing blood samples of similar populations over time, this increase in incidence is not merely due to increased awareness and testing. A key question that researches have been struggling with is: why has this increase in incidence occurred? Some researchers have suggested that there must be a missing environmental factor.
The hypothesis developed by Seth Bittker suggests that supplementation and fortification with oral vitamin D may be such a missing environmental factor. First, the active vitamin D metabolite (1,25-dihydroxyvitamin D) is often elevated in celiac disease, especially in the newly diagnosed. Second, nine distinct conditions that cause elevations in the levels of the active vitamin D metabolite in blood, are associated with increased risk of celiac disease or have indications of such an association in the literature. This suggests that elevation in the vitamin D metabolite in blood may increase the risk of developing celiac disease.
Yet other studies show that oral vitamin D exposure increases blood levels of the active vitamin D metabolite, which makes one wonder whether significant oral vitamin D supplementation and fortification may be a risk factor for celiac disease as well. One study in the literature has found that vitamin D supplementation in infancy is associated with celiac disease. Other studies show that high dose vitamin D supplementation affects the immune system, and the effects on the immune system associated with it is similarly in many ways to the immunological profile of celiac disease.
In addition, a number of epidemiological quirks of celiac disease may be explained by this vitamin D hypothesis. For example, researchers have known for decades that a large increase in incidence of celiac disease occurred in Sweden in 1984. Mandatory vitamin D supplementation of milk in Sweden began in March of 1983. Similarly, researchers are aware that there is significant variation in incidence of celiac disease in certain superficially similar countries. For example, Germany has a low incidence of celiac disease and Sweden and Finland have very high incidences of celiac disease and Vitamin D intake is much higher in Sweden and Finland than in Germany due to differences in fortification and supplementation policies.
While this is a hypothesis and additional research needs to be conducted to test it, if additional research bears it out, it has significant public health implications.
Reference:
Bittker SS. Elevated Levels of 1,25-Dihydroxyvitamin D in Plasma as a Missing Risk Factor for Celiac Disease. Clinical and Experimental Gastroenterology. 2020;13:1-15. https://doi.org/10.2147/CEG.S222353
More information on Seth Bittker is available here: http://ronininstitute.org/research-scholars/seth-bittker/
Seth Bittker
17 Edmond Street
Darien, Connecticut 06820
seth.bittker@ronininstitute.org
Academic Research
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What Is Driving the Increased Incidence of Celiac Disease in Many Developed Countries? here
News-ID: 1928350 • Views: …
More Releases from Seth Bittker

Is Acetaminophen in Infancy a Risk Factor for Autism Spectrum Disorder?
According to two researchers, the answer may be "yes," and the contribution to risk of autism spectrum disorder among males from this factor alone may be significant. Specifically, researchers Seth Bittker and Kathleen Bell found that acetaminophen exposure before age two may contribute to as much as 40% of the risk of autism spectrum disorder among males.
The researchers conducted a survey of parents who have children with autism spectrum…
More Releases for Celiac
Celiac Disease Market Revenue Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users (Hospitals, Homecare), And Distribution Channels (Hospital Pharmacy, Online Pharmacy, And Retail Pharmacy), Region, Market Outlook And Industry Analysis 2031"
The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn…
Celiac Disease Treatment Market
Celiac disease is an autoimmune disorder that affects the small intestine, triggered by the ingestion of gluten-a protein found in wheat, barley, and rye. This condition leads to inflammation and damage in the intestinal lining, which can hinder nutrient absorption and result in various gastrointestinal and systemic symptoms. As awareness of celiac disease grows, so does the demand for effective treatments and dietary solutions. This post delves into the celiac…
Celiac disease Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Celiac disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Celiac disease, historical and forecasted epidemiology as well as the Celiac disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Celiac disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Celiac disease market size…
Celiac Disease Drugs Market to Record an Exponential CAGR
Celiac Disease Drugs Market report analyses the prospects in the market for several shareholders and aspirants by identifying the high-growth segments, main actions approved by them and Celiac Disease Drugs market recent progressions. The Celiac Disease Drugs market report is prepared after fundamental levels of research regarding the Celiac Disease Drugs Industry.
Celiac Disease Drugs Market by Drugs (First Line of Treatment and Second Line of Treatment) - Global Opportunity Analysis…
Celiac disease Market to Observe Strong Development by 2025
The global Celiac Disease Market is prophesied to rake in a heavy demand on account of three decisive factors such as healthy government initiatives, prevalence of the disease, and increased consumption of foods containing gluten.
Governments of different countries such as the U.K., Canada, New Zealand, Australia, and Argentina and the European Union are expected to accelerative initiatives for the treatment of celiac disease. These governments could provide a strong boost…
Celiac disease market: Global Trends and Forecast Analysis 2025
Celiac disease is an autoimmune disorder in which the surface of the small intestine is damaged by a protein called gluten. Gluten is found in rye, barley, and wheat. Gluten triggers an immune reaction in the small intestine damaging the villi (small finger-like projections in the small intestine which promote absorption). The damage restricts the ability of the body to absorb proteins, nutrients, fats, vitamins, carbohydrates, and minerals. Eventually, this…